Triple Diagnosis: Dual Diagnosis and HIV Disease, Part 2

Antoine B. Douaihy, MD, Roger J. Jou, MD, Tad Gorske, PhD, Ihsan M. Salloum, MD, MPH


AIDS Read. 2003;13(8) 

In This Article

Abstract and Introduction

This review highlights the psychiatric, psychosocial, and substance use treatment issues relevant to the care of patients with triple diagnosis. A discussion of the various psychosocial and psychopharmacologic strategies stresses the importance of integrating medical, psychiatric, and substance use interventions. Components of integrated treatment include a collaborative relationship with various medical services involved in the patient's care, psychotherapeutic interventions tailored to the patient's readiness for change and incorporating motivational strategies, special attention to psychosocial needs, strong emphasis on psychoeducation, and psychopharmacologic management. More research is warranted to evaluate the safety and efficacy of psychopharmacologic and psychotherapeutic modalities in patients with triple diagnosis.

Clinical consensus has established the necessity of integrating treatment of substance use disorders and psychiatric disorders in the patient with dual diagnosis.[1] Research on integrated treatment suggests positive outcomes such as decreased hospital use, reduced substance abuse, increased use of community resources, and reduced homelessness.[2,3] Such an approach incorporating HIV care can be applied to treating patients with triple diagnosis in order to optimize psychiatric and medical outcomes. Table 1 identifies the components of integrated treatment.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.
Post as: